Health TrialsbyHealthPanel

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

ConditionCoronavirus Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversità Vita-Salute San Raffaele

About this trial

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients admitted to hospital with biological samples positive for SARS-CoV-2

Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease

Patients discharged from emergency department with biological samples positive for SARS-CoV-2

Disqualifiers

None

Trial population

COVID-19 patients

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Observational Study

    Other intervention

    Not required

Treatment groups

6,000 Participants
are divided into 1 treatment group
Group A: COVID-19 patients1 intervention

Trial outcomes

Primary outcomes

1

Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Time frame
Hospital stay (2-3 weeks)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Università Vita-Salute San Raffaele

Lead sponsor

Source ClinicalTrials.gov
Apply now